rs17849995

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001023570.4(IQCB1):​c.1301G>A​(p.Cys434Tyr) variant causes a missense change. The variant allele was found at a frequency of 0.256 in 1,612,350 control chromosomes in the GnomAD database, including 57,176 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.26 ( 5650 hom., cov: 31)
Exomes 𝑓: 0.26 ( 51526 hom. )

Consequence

IQCB1
NM_001023570.4 missense

Scores

2
16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 3.90

Publications

35 publications found
Variant links:
Genes affected
IQCB1 (HGNC:28949): (IQ motif containing B1) This gene encodes a nephrocystin protein that interacts with calmodulin and the retinitis pigmentosa GTPase regulator protein. The encoded protein has a central coiled-coil region and two calmodulin-binding IQ domains. It is localized to the primary cilia of renal epithelial cells and connecting cilia of photoreceptor cells. The protein is thought to play a role in ciliary function. Defects in this gene result in Senior-Loken syndrome type 5. Alternative splicing results in multiple transcript variants. A pseudogene of this gene is found on chromosome 6. [provided by RefSeq, Jan 2016]
IQCB1 Gene-Disease associations (from GenCC):
  • Senior-Loken syndrome 5
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • Leber congenital amaurosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Senior-Loken syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0013995767).
BP6
Variant 3-121781852-C-T is Benign according to our data. Variant chr3-121781852-C-T is described in ClinVar as Benign. ClinVar VariationId is 257090.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.423 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IQCB1NM_001023570.4 linkc.1301G>A p.Cys434Tyr missense_variant Exon 13 of 15 ENST00000310864.11 NP_001018864.2 Q15051-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IQCB1ENST00000310864.11 linkc.1301G>A p.Cys434Tyr missense_variant Exon 13 of 15 1 NM_001023570.4 ENSP00000311505.6 Q15051-1
IQCB1ENST00000349820.10 linkc.902G>A p.Cys301Tyr missense_variant Exon 10 of 12 1 ENSP00000323756.7 Q15051-2
IQCB1ENST00000393650.7 linkn.*279G>A non_coding_transcript_exon_variant Exon 12 of 14 5 ENSP00000377261.3 Q15051-3
IQCB1ENST00000393650.7 linkn.*279G>A 3_prime_UTR_variant Exon 12 of 14 5 ENSP00000377261.3 Q15051-3

Frequencies

GnomAD3 genomes
AF:
0.259
AC:
39381
AN:
151780
Hom.:
5635
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.235
Gnomad AMI
AF:
0.219
Gnomad AMR
AF:
0.430
Gnomad ASJ
AF:
0.216
Gnomad EAS
AF:
0.167
Gnomad SAS
AF:
0.406
Gnomad FIN
AF:
0.248
Gnomad MID
AF:
0.204
Gnomad NFE
AF:
0.237
Gnomad OTH
AF:
0.269
GnomAD2 exomes
AF:
0.300
AC:
75379
AN:
251354
AF XY:
0.295
show subpopulations
Gnomad AFR exome
AF:
0.231
Gnomad AMR exome
AF:
0.573
Gnomad ASJ exome
AF:
0.235
Gnomad EAS exome
AF:
0.163
Gnomad FIN exome
AF:
0.248
Gnomad NFE exome
AF:
0.240
Gnomad OTH exome
AF:
0.277
GnomAD4 exome
AF:
0.256
AC:
373186
AN:
1460450
Hom.:
51526
Cov.:
35
AF XY:
0.258
AC XY:
187809
AN XY:
726566
show subpopulations
African (AFR)
AF:
0.229
AC:
7669
AN:
33452
American (AMR)
AF:
0.556
AC:
24852
AN:
44700
Ashkenazi Jewish (ASJ)
AF:
0.228
AC:
5965
AN:
26110
East Asian (EAS)
AF:
0.160
AC:
6331
AN:
39636
South Asian (SAS)
AF:
0.389
AC:
33529
AN:
86226
European-Finnish (FIN)
AF:
0.246
AC:
13141
AN:
53336
Middle Eastern (MID)
AF:
0.236
AC:
1359
AN:
5762
European-Non Finnish (NFE)
AF:
0.239
AC:
264984
AN:
1110910
Other (OTH)
AF:
0.255
AC:
15356
AN:
60318
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.466
Heterozygous variant carriers
0
13766
27533
41299
55066
68832
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
9272
18544
27816
37088
46360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.260
AC:
39429
AN:
151900
Hom.:
5650
Cov.:
31
AF XY:
0.268
AC XY:
19887
AN XY:
74226
show subpopulations
African (AFR)
AF:
0.235
AC:
9742
AN:
41432
American (AMR)
AF:
0.431
AC:
6573
AN:
15238
Ashkenazi Jewish (ASJ)
AF:
0.216
AC:
748
AN:
3466
East Asian (EAS)
AF:
0.167
AC:
864
AN:
5170
South Asian (SAS)
AF:
0.405
AC:
1943
AN:
4796
European-Finnish (FIN)
AF:
0.248
AC:
2609
AN:
10540
Middle Eastern (MID)
AF:
0.207
AC:
61
AN:
294
European-Non Finnish (NFE)
AF:
0.237
AC:
16129
AN:
67944
Other (OTH)
AF:
0.266
AC:
561
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1425
2850
4274
5699
7124
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
416
832
1248
1664
2080
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.248
Hom.:
9221
Bravo
AF:
0.268
TwinsUK
AF:
0.248
AC:
920
ALSPAC
AF:
0.250
AC:
963
ESP6500AA
AF:
0.233
AC:
1026
ESP6500EA
AF:
0.239
AC:
2057
ExAC
AF:
0.289
AC:
35062
Asia WGS
AF:
0.313
AC:
1088
AN:
3478
EpiCase
AF:
0.242
EpiControl
AF:
0.238

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Senior-Loken syndrome 5 Benign:3
May 28, 2019
Mendelics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Aug 19, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nephronophthisis Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.40
T
BayesDel_noAF
Benign
-0.21
CADD
Benign
21
DANN
Benign
0.82
DEOGEN2
Benign
0.060
T;.
Eigen
Benign
-0.12
Eigen_PC
Benign
-0.12
FATHMM_MKL
Uncertain
0.82
D
LIST_S2
Benign
0.78
T;T
MetaRNN
Benign
0.0014
T;T
MetaSVM
Benign
-0.96
T
MutationAssessor
Benign
2.0
M;.
PhyloP100
3.9
PrimateAI
Uncertain
0.60
T
PROVEAN
Benign
-1.7
N;N
REVEL
Benign
0.20
Sift
Benign
0.16
T;T
Sift4G
Benign
0.17
T;T
Polyphen
0.83
P;D
Vest4
0.24
MPC
0.40
ClinPred
0.025
T
GERP RS
3.7
Varity_R
0.12
gMVP
0.40
Mutation Taster
=86/14
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17849995; hg19: chr3-121500699; COSMIC: COSV60436034; API